IDV vehicle
36E79721A0020
BPA FOR FERRIPROX, REVCOVI
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | NAC PHARMACEUTICALS (36E797) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | 36F79720D0214 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $0 |
| Current contract value | Not reported |
| Potential contract value / ceiling | $2.2M |
| Start date | Sep 10, 2021 |
| Current end date | Not available |
| Potential end date | Not available |
| Latest award activity | Dec 12, 2025 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 7 of 7 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Dec 12, 2025 | P00019 | $0 | 2026 PUBLIC LAW PRICING UPDATES. |
| Jul 31, 2025 | P00017 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE THE PRODUCT ADDITIONS OF 4 JUXTAPID NDCS AND 1 ELFABRIO NDC TO BPA 36E79721A0020, ALONG WITH THE DELETION OF 1 JUXTAPID NDC. |
| Jul 31, 2025 | P00018 | $0 | THIS MODIFICATION IS ISSUED TO EXERCISE OPTION YEAR 4 ON BPA 36E79721A0020. |
| Apr 14, 2025 | P00016 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE THE PRODUCT ADDITIONS OF 4 JUXTAPID NDCS AND 1 ELFABRIO NDC TO BPA 36E79721A0020, ALONG WITH THE DELETION OF 1 JUXTAPID NDC. |
| Dec 20, 2024 | P00014 | $0 | THIS MODIFICATION IS ISSUED TO DELETE 2 BRONCHITOL NDCS FROM BPA 36E79721A0020. |
| Dec 20, 2024 | P00015 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE 2025 PUBLIC LAW PRICING UPDATES INTO BPA 36E79721A0020. |
| Dec 19, 2024 | P00013 | $0 | THIS MODIFICATION IS ISSUED TO INCORPORATE A PRICE INCREASE TO 3 NDCS ON BPA 36E79721A0020. |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.